BLCO Bausch + Lomb Corporation

Bausch & Lomb Corp is a global eye health company dedicated towards protecting and enhancing the gift of sight for millions of people around the world. It holds portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.

$15.02  -0.68 (-4.33%)
As of 06/28/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  
IPO date:  05/06/2022
Outstanding shares:  350,000,000
Average volume:  1,060,942
Market cap:   $5,547,500,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   77.39
PB ratio:   0.77
PS ratio:   1.47
Return on equity:   -1.93%
Net income %:   -4.88%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy